2018 Q4 Form 10-Q Financial Statement

#000107068018000039 Filed on November 09, 2018

View on sec.gov

Income Statement

Concept 2018 Q4 2018 Q3 2017 Q3
Revenue $6.621M $4.397M
YoY Change 50.58%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $100.0K $100.0K
YoY Change 0.0% 0.0%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $1.938M $893.0K
YoY Change 117.02%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $1.650M $1.294M $1.017M
YoY Change 63.37% 27.24% 35.6%
Income Tax $350.0K $239.0K $332.0K
% Of Pretax Income 21.21% 18.47% 32.65%
Net Earnings $1.300M $1.055M $685.0K
YoY Change -533.33% 54.01% 34.31%
Net Earnings / Revenue 15.93% 15.58%
Basic Earnings Per Share $0.24 $0.16
Diluted Earnings Per Share $298.9K $0.24 $0.15
COMMON SHARES
Basic Shares Outstanding 4.298M 4.252M 2.960M
Diluted Shares Outstanding 4.367M 4.458M

Balance Sheet

Concept 2018 Q4 2018 Q3 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $67.30M $59.37M $27.96M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $3.864M $3.723M $3.600M
YoY Change 9.37% 3.42% 2.86%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $665.0M $606.4M $448.9M
YoY Change 38.14% 35.08% 9.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.600M $3.600M $3.100M
YoY Change 53.33% 16.13% 29.17%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.600M $3.600M $3.100M
YoY Change 53.33% 16.13% 29.17%
LONG-TERM LIABILITIES
Long-Term Debt $14.80M $5.200M $5.200M
YoY Change 184.62% 0.0% 0.0%
Other Long-Term Liabilities $800.0K $400.0K $200.0K
YoY Change 60.0% 100.0% -33.33%
Total Long-Term Liabilities $15.60M $5.600M $5.400M
YoY Change 173.68% 3.7% -1.82%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.600M $3.600M $3.100M
Total Long-Term Liabilities $15.60M $5.600M $5.400M
Total Liabilities $619.5M $562.8M $408.4M
YoY Change 40.42% 37.8% 10.59%
SHAREHOLDERS EQUITY
Retained Earnings -$12.75M -$14.17M
YoY Change -25.37%
Common Stock $44.00K $43.00K
YoY Change 2.33%
Preferred Stock
YoY Change
Treasury Stock (at cost) $3.366M $3.324M
YoY Change 1.26%
Treasury Stock Shares $31.24K $27.70K
Shareholders Equity $45.56M $43.59M $40.55M
YoY Change
Total Liabilities & Shareholders Equity $665.0M $606.4M $448.9M
YoY Change 38.14% 35.08% 9.92%

Cashflow Statement

Concept 2018 Q4 2018 Q3 2017 Q3
OPERATING ACTIVITIES
Net Income $1.300M $1.055M $685.0K
YoY Change -533.33% 54.01% 34.31%
Depreciation, Depletion And Amortization $0.00 $100.0K $100.0K
YoY Change 0.0% 0.0%
Cash From Operating Activities $8.300M $3.200M -$2.100M
YoY Change 137.14% -252.38% -240.0%
INVESTING ACTIVITIES
Capital Expenditures -$200.0K -$100.0K -$200.0K
YoY Change -50.0%
Acquisitions
YoY Change
Other Investing Activities -$56.50M -$22.60M -$20.90M
YoY Change 203.76% 8.13% 326.53%
Cash From Investing Activities -$56.60M -$22.80M -$21.20M
YoY Change 204.3% 7.55% 332.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 56.30M 46.10M 17.00M
YoY Change 72.17% 171.18% -60.28%
NET CHANGE
Cash From Operating Activities 8.300M 3.200M -2.100M
Cash From Investing Activities -56.60M -22.80M -21.20M
Cash From Financing Activities 56.30M 46.10M 17.00M
Net Change In Cash 8.000M 26.50M -6.300M
YoY Change -54.55% -520.63% -115.99%
FREE CASH FLOW
Cash From Operating Activities $8.300M $3.200M -$2.100M
Capital Expenditures -$200.0K -$100.0K -$200.0K
Free Cash Flow $8.500M $3.300M -$1.900M
YoY Change 142.86% -273.68% -226.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q4 cfbk Allocated Specific Reserves To Modified Tdrs
AllocatedSpecificReservesToModifiedTdrs
26000
CY2018Q3 cfbk Allocated Specific Reserves To Modified Tdrs
AllocatedSpecificReservesToModifiedTdrs
24000
CY2016Q1 cfbk Capital Conservation Buffer
CapitalConservationBuffer
0.00625
CY2018Q3 cfbk Capital Conservation Buffer
CapitalConservationBuffer
0.025
CY2018Q3 cfbk Capital Conservation Buffer Tier1 Capital
CapitalConservationBufferTier1Capital
0.0188
cfbk Capital Conservative Buffer Phase Period
CapitalConservativeBufferPhasePeriod
P4Y
cfbk Cash Dividends And Adjustments To Additional Paid In Capital Related To Warrants
CashDividendsAndAdjustmentsToAdditionalPaidInCapitalRelatedToWarrants
-562000
cfbk Change In Fair Value
ChangeInFairValue
43000
CY2017Q3 cfbk Change In Fair Value
ChangeInFairValue
23000
cfbk Change In Fair Value
ChangeInFairValue
517000
CY2018Q3 cfbk Common Equity Tier1 Capital To Risk Weighted Assets Ratio
CommonEquityTier1CapitalToRiskWeightedAssetsRatio
0.045
CY2018Q3 cfbk Common Equity Tier1 Capital To Risk Weighted Assets Upon Full Implementation Ratio
CommonEquityTier1CapitalToRiskWeightedAssetsUponFullImplementationRatio
0.070
CY2017Q4 cfbk Common Equity Tier1 Core Capital To Risk Weighted Assets Fully Phased In Actual Amount
CommonEquityTier1CoreCapitalToRiskWeightedAssetsFullyPhasedInActualAmount
28372000
CY2018Q3 cfbk Common Equity Tier1 Core Capital To Risk Weighted Assets Fully Phased In Actual Amount
CommonEquityTier1CoreCapitalToRiskWeightedAssetsFullyPhasedInActualAmount
34847000
CY2017Q4 cfbk Common Equity Tier1 Core Capital To Risk Weighted Assets Fully Phased In Ratio
CommonEquityTier1CoreCapitalToRiskWeightedAssetsFullyPhasedInRatio
0.0700
CY2018Q3 cfbk Common Equity Tier1 Core Capital To Risk Weighted Assets Fully Phased In Ratio
CommonEquityTier1CoreCapitalToRiskWeightedAssetsFullyPhasedInRatio
0.0700
CY2017Q4 cfbk Common Equity Tier1 Core Capital To Risk Weighted Assets Phase In Schedule Actual Amount
CommonEquityTier1CoreCapitalToRiskWeightedAssetsPhaseInScheduleActualAmount
23306000
CY2018Q3 cfbk Common Equity Tier1 Core Capital To Risk Weighted Assets Phase In Schedule Actual Amount
CommonEquityTier1CoreCapitalToRiskWeightedAssetsPhaseInScheduleActualAmount
31761000
CY2017Q4 cfbk Common Equity Tier1 Core Capital To Risk Weighted Assets Phase In Schedule Actual Ratio
CommonEquityTier1CoreCapitalToRiskWeightedAssetsPhaseInScheduleActualRatio
0.0575
CY2018Q3 cfbk Common Equity Tier1 Core Capital To Risk Weighted Assets Phase In Schedule Actual Ratio
CommonEquityTier1CoreCapitalToRiskWeightedAssetsPhaseInScheduleActualRatio
0.0638
CY2017Q4 cfbk Common Equity Tier One Risk Based Capital
CommonEquityTierOneRiskBasedCapital
43179000
CY2018Q3 cfbk Common Equity Tier One Risk Based Capital
CommonEquityTierOneRiskBasedCapital
53740000
CY2017Q4 cfbk Common Equity Tier One Risk Based Capital Required To Be Well Capitalized
CommonEquityTierOneRiskBasedCapitalRequiredToBeWellCapitalized
26346000
CY2018Q3 cfbk Common Equity Tier One Risk Based Capital Required To Be Well Capitalized
CommonEquityTierOneRiskBasedCapitalRequiredToBeWellCapitalized
32358000
CY2017Q4 cfbk Common Equity Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets
CommonEquityTierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.0650
CY2017Q4 cfbk Derivative Weighted Average Receive Rate
DerivativeWeightedAverageReceiveRate
0.0152
CY2017Q3 cfbk Gain Loss On Loans Held For Sale
GainLossOnLoansHeldForSale
-3000
cfbk Gain Loss On Loans Held For Sale
GainLossOnLoansHeldForSale
66000
CY2018Q3 cfbk Gain Loss On Loans Held For Sale
GainLossOnLoansHeldForSale
-208000
CY2018Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-36000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
217000
CY2017Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
6000
CY2017Q3 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
0
CY2018Q3 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
0
CY2017Q3 us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
20000
us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
985000
CY2018Q3 us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
695000
CY2018Q3 cfbk Change In Fair Value
ChangeInFairValue
77000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.330
CY2017Q3 us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
23000
us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
1268000
CY2018Q3 us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
451000
CY2018Q3 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Net
EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet
9000
CY2018Q3 cfbk Fair Value Option Loans Held As Assets Contractual Amount
FairValueOptionLoansHeldAsAssetsContractualAmount
24009000
CY2018Q3 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
3425000
CY2018Q3 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
51000
CY2018Q3 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
46000
CY2018Q3 us-gaap Interest And Fee Income Loans And Leases Held For Sale
InterestAndFeeIncomeLoansAndLeasesHeldForSale
285000
CY2017Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4458296
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4342271
CY2018Q3 invest Derivative Notional Amount
DerivativeNotionalAmount
1378000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.91
CY2003Q4 us-gaap Subordinated Debt
SubordinatedDebt
5155000
us-gaap Derivative Average Remaining Maturity1
DerivativeAverageRemainingMaturity1
P2Y2M12D
CY2017Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Net
EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet
56000
CY2018Q3 us-gaap Fair Value Option Loans Held As Assets Aggregate Difference
FairValueOptionLoansHeldAsAssetsAggregateDifference
70000
CY2017Q3 cfbk Interest Expense Loans And Leases Heldforsale
InterestExpenseLoansAndLeasesHeldforsale
cfbk Interest Expense Loans And Leases Heldforsale
InterestExpenseLoansAndLeasesHeldforsale
CY2018Q3 cfbk Common Equity Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets
CommonEquityTierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.0650
CY2017Q4 cfbk Common Equity Tier One Risk Based Capital To Risk Weighted Assets
CommonEquityTierOneRiskBasedCapitalToRiskWeightedAssets
0.1065
CY2018Q3 cfbk Common Equity Tier One Risk Based Capital To Risk Weighted Assets
CommonEquityTierOneRiskBasedCapitalToRiskWeightedAssets
0.1080
cfbk Common Stock Warrant
CommonStockWarrant
<div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt 0pt 8pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">NOTE 14 - COMMON STOCK WARRANTS</font> </p> <p style="margin:0pt 0pt 8pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Series B Preferred Stock &#x2013; Warrants:</font> </p> <p style="margin:0pt 0pt 8pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">For each share of Series B Preferred Stock issued by the Company in the Private Placement, the Company also issued, at no additional charge, a Warrant to purchase (i) </font><font style="display: inline;">2.00</font><font style="display: inline;"> shares of common stock</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">of the Company (</font><font style="display: inline;">or 0.364</font><font style="display: inline;"> shares on a post-reverse-split basis) if the purchaser purchased less than </font><font style="display: inline;">$700</font><font style="display: inline;"> &nbsp;(</font><font style="display: inline;">28,000</font><font style="display: inline;"> shares) of Series B Preferred Stock in the Private Placement, or (ii) </font><font style="display: inline;">3.25</font><font style="display: inline;"> shares of common stock (or 0.591 shares on a post-reverse-split basis) if the purchaser purchased </font><font style="display: inline;">$700</font><font style="display: inline;"> &nbsp;(</font><font style="display: inline;">28,000</font><font style="display: inline;"> shares) or more of Series B Preferred Stock in the Private Placement.&nbsp;&nbsp;Warrants to purchase an aggregate of </font><font style="display: inline;">1,152,125</font><font style="display: inline;"> shares of common st</font><font style="display: inline;">ock (or </font><font style="display: inline;">209,477</font><font style="display: inline;"> shares</font><font style="display: inline;"> on a post-reverse-split basis) were issued by the Company to the purchasers of the </font><font style="display: inline;">480,000</font><font style="display: inline;"> shares of Series B Preferred Stock sold in the Private Placement.&nbsp;&nbsp;The Warrants are exercisable for a period of approximately </font><font style="display: inline;">five</font><font style="display: inline;"> (5) years expiring on July 15, 2019, at an exercise price of </font><font style="display: inline;">$10.18</font><font style="display: inline;"> (on a post-reverse-split basis) per share of common stock.&nbsp; </font><font style="display: inline;">As of September&nbsp;30, 2018, warrants to purchase an aggregate </font><font style="display: inline;">of 191,569</font><font style="display: inline;"> shares of common stock (on a post-reverse-split basis) were outstanding. </font> </p> <p style="margin:0pt 0pt 8pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div>
CY2017Q4 cfbk Deferred Tax Assets Operating Loss Carryforwards That Will Expire Unutilized Federal
DeferredTaxAssetsOperatingLossCarryforwardsThatWillExpireUnutilizedFederal
20520000
CY2017Q4 cfbk Derivative Weighted Average Pay Rate
DerivativeWeightedAveragePayRate
0.0375
CY2018Q3 cfbk Derivative Weighted Average Pay Rate
DerivativeWeightedAveragePayRate
0.0312
CY2018Q3 cfbk Derivative Weighted Average Receive Rate
DerivativeWeightedAverageReceiveRate
0.0220
CY2017Q4 cfbk Fair Value Assets And Liabilities Transfer Level1 To Level3
FairValueAssetsAndLiabilitiesTransferLevel1ToLevel3
0
CY2018Q3 cfbk Fair Value Assets And Liabilities Transfer Level1 To Level3
FairValueAssetsAndLiabilitiesTransferLevel1ToLevel3
0
CY2017Q4 cfbk Fair Value Assets And Liabilities Transfer Level3 To Level1
FairValueAssetsAndLiabilitiesTransferLevel3ToLevel1
0
CY2018Q3 cfbk Fair Value Assets And Liabilities Transfer Level3 To Level1
FairValueAssetsAndLiabilitiesTransferLevel3ToLevel1
0
CY2017Q4 cfbk Fair Value Option Loans Held As Assets Contractual Amount
FairValueOptionLoansHeldAsAssetsContractualAmount
1120000
CY2017Q4 cfbk Financing Receivable Recorded Investment Nonaccrual Loans Not90 Days Past Due
FinancingReceivableRecordedInvestmentNonaccrualLoansNot90DaysPastDue
264000
CY2018Q3 cfbk Financing Receivable Recorded Investment Nonaccrual Loans Not90 Days Past Due
FinancingReceivableRecordedInvestmentNonaccrualLoansNot90DaysPastDue
344000
cfbk Future Percent Common Equity Of Risk Weighted Assets
FuturePercentCommonEquityOfRiskWeightedAssets
0.025
cfbk Gain Loss On Loans Held For Sale
GainLossOnLoansHeldForSale
-12000
cfbk Gain On Sale Of Foreclosed Assets
GainOnSaleOfForeclosedAssets
-7000
CY2017Q4 cfbk Impaired Financing Receivable Allocated Allowance Loans And Leases
ImpairedFinancingReceivableAllocatedAllowanceLoansAndLeases
26000
CY2018Q3 cfbk Impaired Financing Receivable Allocated Allowance Loans And Leases
ImpairedFinancingReceivableAllocatedAllowanceLoansAndLeases
24000
CY2017 cfbk Impaired Financing Receivable Rounding Threshold
ImpairedFinancingReceivableRoundingThreshold
1000
cfbk Impaired Financing Receivable Rounding Threshold
ImpairedFinancingReceivableRoundingThreshold
1000
cfbk Incometaxeffectrecognizedonconsolidatedbalancesheetforsharebasedcompensationarrangements
Incometaxeffectrecognizedonconsolidatedbalancesheetforsharebasedcompensationarrangements
62000
CY2017Q3 cfbk Incometaxeffectrecognizedonconsolidatedbalancesheetforsharebasedcompensationarrangements
Incometaxeffectrecognizedonconsolidatedbalancesheetforsharebasedcompensationarrangements
20000
cfbk Incometaxeffectrecognizedonconsolidatedbalancesheetforsharebasedcompensationarrangements
Incometaxeffectrecognizedonconsolidatedbalancesheetforsharebasedcompensationarrangements
61000
CY2018Q3 cfbk Incometaxeffectrecognizedonconsolidatedbalancesheetforsharebasedcompensationarrangements
Incometaxeffectrecognizedonconsolidatedbalancesheetforsharebasedcompensationarrangements
21000
cfbk Interest Expense Loans And Leases Heldforsale
InterestExpenseLoansAndLeasesHeldforsale
CY2018Q3 cfbk Interest Expense Loans And Leases Heldforsale
InterestExpenseLoansAndLeasesHeldforsale
CY2018Q3 cfbk Line Of Credit Facility Increase Decrease In Borrowing Capacity
LineOfCreditFacilityIncreaseDecreaseInBorrowingCapacity
2000000
cfbk Loans Issued To Finance Sale Of Repossessed Assets
LoansIssuedToFinanceSaleOfRepossessedAssets
288000
CY2017Q3 cfbk Loans Modified Not Troubled Debt Restructurings Recorded Investment
LoansModifiedNotTroubledDebtRestructuringsRecordedInvestment
10843000
CY2018Q3 cfbk Loans Modified Not Troubled Debt Restructurings Recorded Investment
LoansModifiedNotTroubledDebtRestructuringsRecordedInvestment
10210000
CY2018Q3 cfbk Minimum Leverage Ratio Based On Required Basel3 Rules
MinimumLeverageRatioBasedOnRequiredBasel3Rules
0.040
CY2017Q4 us-gaap Direct Financing Lease Lease Receivable
DirectFinancingLeaseLeaseReceivable
6838000
CY2018Q3 us-gaap Direct Financing Lease Lease Receivable
DirectFinancingLeaseLeaseReceivable
6244000
CY2017Q4 us-gaap Direct Financing Lease Net Investment In Lease
DirectFinancingLeaseNetInvestmentInLease
6008000
CY2018Q3 us-gaap Direct Financing Lease Net Investment In Lease
DirectFinancingLeaseNetInvestmentInLease
5557000
CY2017Q4 cfbk Mortgage Servicing Rights Msr Valuation Allowances
MortgageServicingRightsMsrValuationAllowances
24000
CY2018Q3 cfbk Mortgage Servicing Rights Msr Valuation Allowances
MortgageServicingRightsMsrValuationAllowances
24000
cfbk Number Of Days Of Default Payment
NumberOfDaysOfDefaultPayment
P90D
cfbk Number Of Stock Based Compensation Plans
NumberOfStockBasedCompensationPlans
2
CY2018Q3 cfbk Opening Balance In Liquidation Account
OpeningBalanceInLiquidationAccount
14300000
CY2017 cfbk Operating Loss Carryforwards Limitations On Use Amount
OperatingLossCarryforwardsLimitationsOnUseAmount
163000
cfbk Other Insurance
OtherInsurance
70000
CY2017Q3 cfbk Other Insurance
OtherInsurance
21000
cfbk Other Insurance
OtherInsurance
63000
CY2018Q3 cfbk Other Insurance
OtherInsurance
22000
CY2017Q4 cfbk Pledged Assets Separately Reported Securities Pledged For Interest Rate Swaps At Fair Value
PledgedAssetsSeparatelyReportedSecuritiesPledgedForInterestRateSwapsAtFairValue
145000
CY2018Q3 cfbk Pledged Assets Separately Reported Securities Pledged For Interest Rate Swaps At Fair Value
PledgedAssetsSeparatelyReportedSecuritiesPledgedForInterestRateSwapsAtFairValue
113000
CY2017Q4 cfbk Pledged Assets Separately Reported Securities Pledged For Public Deposits At Fair Value
PledgedAssetsSeparatelyReportedSecuritiesPledgedForPublicDepositsAtFairValue
2018000
CY2018Q3 cfbk Pledged Assets Separately Reported Securities Pledged For Public Deposits At Fair Value
PledgedAssetsSeparatelyReportedSecuritiesPledgedForPublicDepositsAtFairValue
1988000
cfbk Regulatory Assessment
RegulatoryAssessment
95000
CY2017Q3 cfbk Regulatory Assessment
RegulatoryAssessment
31000
cfbk Regulatory Assessment
RegulatoryAssessment
103000
CY2018Q3 cfbk Regulatory Assessment
RegulatoryAssessment
34000
CY2017Q4 cfbk Tax Cuts And Jobs Act Of2017 Income Tax Expense Benefit
TaxCutsAndJobsActOf2017IncomeTaxExpenseBenefit
979000
CY2018Q3 cfbk Tier1 Capital To Risk Weighted Assets Ratio
Tier1CapitalToRiskWeightedAssetsRatio
0.060
CY2018Q3 cfbk Tier1 Capital To Risk Weighted Assets Upon Full Implementation Ratio
Tier1CapitalToRiskWeightedAssetsUponFullImplementationRatio
0.085
CY2017Q4 cfbk Tier1 Core Capital To Adjusted Total Assets Fully Phased In Actual Amount
Tier1CoreCapitalToAdjustedTotalAssetsFullyPhasedInActualAmount
18432000
CY2018Q3 cfbk Tier1 Core Capital To Adjusted Total Assets Fully Phased In Actual Amount
Tier1CoreCapitalToAdjustedTotalAssetsFullyPhasedInActualAmount
22832000
CY2017Q4 cfbk Tier1 Core Capital To Adjusted Total Assets Fully Phased In Ratio
Tier1CoreCapitalToAdjustedTotalAssetsFullyPhasedInRatio
0.0400
CY2018Q3 cfbk Tier1 Core Capital To Adjusted Total Assets Fully Phased In Ratio
Tier1CoreCapitalToAdjustedTotalAssetsFullyPhasedInRatio
0.0400
CY2017Q4 cfbk Tier1 Core Capital To Adjusted Total Assets Phase In Schedule Actual Amount
Tier1CoreCapitalToAdjustedTotalAssetsPhaseInScheduleActualAmount
18432000
CY2018Q3 cfbk Tier1 Core Capital To Adjusted Total Assets Phase In Schedule Actual Amount
Tier1CoreCapitalToAdjustedTotalAssetsPhaseInScheduleActualAmount
22832000
CY2017Q4 cfbk Tier1 Core Capital To Adjusted Total Assets Phase In Schedule Actual Ratio
Tier1CoreCapitalToAdjustedTotalAssetsPhaseInScheduleActualRatio
0.0400
CY2018Q3 cfbk Tier1 Core Capital To Adjusted Total Assets Phase In Schedule Actual Ratio
Tier1CoreCapitalToAdjustedTotalAssetsPhaseInScheduleActualRatio
0.0400
CY2017Q4 cfbk Tier1 Core Capital To Risk Weighted Assets Fully Phased In Actual Amount
Tier1CoreCapitalToRiskWeightedAssetsFullyPhasedInActualAmount
34452000
CY2018Q3 cfbk Tier1 Core Capital To Risk Weighted Assets Fully Phased In Actual Amount
Tier1CoreCapitalToRiskWeightedAssetsFullyPhasedInActualAmount
42314000
CY2017Q4 cfbk Tier1 Core Capital To Risk Weighted Assets Fully Phased In Ratio
Tier1CoreCapitalToRiskWeightedAssetsFullyPhasedInRatio
0.0850
CY2018Q3 cfbk Tier1 Core Capital To Risk Weighted Assets Fully Phased In Ratio
Tier1CoreCapitalToRiskWeightedAssetsFullyPhasedInRatio
0.0850
CY2017Q4 cfbk Tier1 Core Capital To Risk Weighted Assets Phase In Schedule Actual Amount
Tier1CoreCapitalToRiskWeightedAssetsPhaseInScheduleActualAmount
29386000
CY2018Q3 cfbk Tier1 Core Capital To Risk Weighted Assets Phase In Schedule Actual Amount
Tier1CoreCapitalToRiskWeightedAssetsPhaseInScheduleActualAmount
39228000
CY2017Q4 cfbk Tier1 Core Capital To Risk Weighted Assets Phase In Schedule Actual Ratio
Tier1CoreCapitalToRiskWeightedAssetsPhaseInScheduleActualRatio
0.0725
CY2018Q3 cfbk Tier1 Core Capital To Risk Weighted Assets Phase In Schedule Actual Ratio
Tier1CoreCapitalToRiskWeightedAssetsPhaseInScheduleActualRatio
0.0788
CY2017Q4 cfbk Total Capital To Risk Weighted Assets Fully Phased In Actual Amount
TotalCapitalToRiskWeightedAssetsFullyPhasedInActualAmount
42559000
CY2018Q3 cfbk Total Capital To Risk Weighted Assets Fully Phased In Actual Amount
TotalCapitalToRiskWeightedAssetsFullyPhasedInActualAmount
52271000
CY2017Q4 cfbk Total Capital To Risk Weighted Assets Fully Phased In Ratio
TotalCapitalToRiskWeightedAssetsFullyPhasedInRatio
0.1050
CY2018Q3 cfbk Total Capital To Risk Weighted Assets Fully Phased In Ratio
TotalCapitalToRiskWeightedAssetsFullyPhasedInRatio
0.1050
CY2017Q4 cfbk Total Capital To Risk Weighted Assets Phase In Schedule Actual Amount
TotalCapitalToRiskWeightedAssetsPhaseInScheduleActualAmount
37492000
CY2018Q3 cfbk Total Capital To Risk Weighted Assets Phase In Schedule Actual Amount
TotalCapitalToRiskWeightedAssetsPhaseInScheduleActualAmount
49184000
CY2017Q4 cfbk Total Capital To Risk Weighted Assets Phase In Schedule Actual Ratio
TotalCapitalToRiskWeightedAssetsPhaseInScheduleActualRatio
0.0925
CY2018Q3 cfbk Total Capital To Risk Weighted Assets Phase In Schedule Actual Ratio
TotalCapitalToRiskWeightedAssetsPhaseInScheduleActualRatio
0.0988
CY2018Q3 cfbk Total Capital To Risk Weighted Assets Ratio
TotalCapitalToRiskWeightedAssetsRatio
0.080
CY2018Q3 cfbk Total Capital To Risk Weighted Assets Upon Full Implementation Ratio
TotalCapitalToRiskWeightedAssetsUponFullImplementationRatio
0.105
CY2017Q4 cfbk Trouble Debt Restructuring Accrual Financial Receivables
TroubleDebtRestructuringAccrualFinancialReceivables
3271000
CY2018Q3 cfbk Trouble Debt Restructuring Accrual Financial Receivables
TroubleDebtRestructuringAccrualFinancialReceivables
3163000
CY2017Q4 cfbk Unpaid Principal Balance Of Impaired Loans Carried At Fair Value Of Collateral
UnpaidPrincipalBalanceOfImpairedLoansCarriedAtFairValueOfCollateral
3087000
CY2018Q3 cfbk Unpaid Principal Balance Of Impaired Loans Carried At Fair Value Of Collateral
UnpaidPrincipalBalanceOfImpairedLoansCarriedAtFairValueOfCollateral
3042000
cfbk Unvested Share Based Payment Awards
UnvestedShareBasedPaymentAwards
CY2017Q3 cfbk Unvested Share Based Payment Awards
UnvestedShareBasedPaymentAwards
cfbk Unvested Share Based Payment Awards
UnvestedShareBasedPaymentAwards
CY2018Q3 cfbk Unvested Share Based Payment Awards
UnvestedShareBasedPaymentAwards
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
dei Document Period End Date
DocumentPeriodEndDate
2018-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001070680
CY2018Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4298044
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
CENTRAL FEDERAL CORP
dei Entity Small Business
EntitySmallBusiness
true
dei Trading Symbol
TradingSymbol
cfbk
CY2017Q4 invest Derivative Notional Amount
DerivativeNotionalAmount
2185000
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
2992000
CY2018Q3 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
3626000
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-47000
CY2018Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-132000
CY2017Q3 us-gaap Accumulated Other Comprehensive Income Loss Other Than Temporary Impairment Not Credit Loss Net Of Tax Availableforsale Debt Securities
AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxAvailableforsaleDebtSecurities
0
CY2018Q3 us-gaap Accumulated Other Comprehensive Income Loss Other Than Temporary Impairment Not Credit Loss Net Of Tax Availableforsale Debt Securities
AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxAvailableforsaleDebtSecurities
0
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
60676000
CY2018Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
61174000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
-83000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
-19000
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
181000
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
290000
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
144000
CY2017Q4 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
489000
CY2018Q3 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
449000
us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
6000
CY2018Q3 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
39000
CY2017Q3 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
6000
us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
41000
CY2018Q3 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
24000
CY2017Q4 us-gaap Assets
Assets
481425000
CY2018Q3 us-gaap Assets
Assets
606379000
CY2017Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
11845000
CY2018Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
11231000
CY2017Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
11773000
CY2018Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
11064000
CY2017Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
10000
CY2018Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
4000
CY2017Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
82000
CY2018Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
171000
CY2017Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
11845000
CY2018Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
11231000
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
31000
CY2018Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
89000
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
82000
CY2018Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
171000
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
11417000
CY2018Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
10804000
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
51000
CY2018Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
82000
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
6947000
CY2018Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
4893000
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
4470000
CY2018Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
5911000
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
8497000
CY2018Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
7477000
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
8424000
CY2018Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
7328000
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
3002000
CY2018Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
3498000
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
2993000
CY2018Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
3476000
CY2017Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
11773000
CY2018Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
11064000
CY2017Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
5065000
CY2018Q3 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
5168000
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
100000
CY2017Q3 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
33000
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
102000
CY2018Q3 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
34000
CY2017Q4 us-gaap Capital
Capital
48271000
CY2018Q3 us-gaap Deposits
Deposits
532062000
CY2018Q3 us-gaap Fair Value Option Loans Held As Assets90 Days Or More Past Due
FairValueOptionLoansHeldAsAssets90DaysOrMorePastDue
0
CY2018Q3 us-gaap Interest Rate Derivatives At Fair Value Net
InterestRateDerivativesAtFairValueNet
-9000
CY2017Q4 us-gaap Fair Value Option Loans Held As Assets90 Days Or More Past Due
FairValueOptionLoansHeldAsAssets90DaysOrMorePastDue
0
CY2018Q3 us-gaap Capital
Capital
59974000
CY2017Q4 us-gaap Capital Required To Be Well Capitalized
CapitalRequiredToBeWellCapitalized
40532000
CY2018Q3 us-gaap Capital Required To Be Well Capitalized
CapitalRequiredToBeWellCapitalized
49782000
CY2017Q4 us-gaap Capital Required To Be Well Capitalized To Risk Weighted Assets
CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.1000
CY2018Q3 us-gaap Capital Required To Be Well Capitalized To Risk Weighted Assets
CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.1000
CY2017Q4 us-gaap Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
0.1191
CY2018Q3 us-gaap Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
0.1205
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45498000
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
59368000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57941000
CY2017Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27956000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45498000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
59368000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-29985000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
13870000
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
272727
CY2003Q4 us-gaap Common Stock Held In Trust
CommonStockHeldInTrust
155000
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
9090909
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
9090909
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4273085
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4279657
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
43000
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
43000
us-gaap Communication
Communication
89000
CY2017Q3 us-gaap Communication
Communication
29000
us-gaap Communication
Communication
113000
CY2018Q3 us-gaap Communication
Communication
43000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1639000
CY2017Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
682000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2892000
CY2018Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1039000
CY2017Q4 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
480000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-30000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
10000
CY2017Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1600000
CY2018Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1600000
CY2017Q4 us-gaap Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Policyholders Surplus
DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus
473000
CY2017Q4 us-gaap Deposits
Deposits
419028000
us-gaap Depreciation
Depreciation
150000
us-gaap Depreciation
Depreciation
188000
us-gaap Depreciation Nonproduction
DepreciationNonproduction
150000
CY2017Q3 us-gaap Depreciation Nonproduction
DepreciationNonproduction
49000
us-gaap Depreciation Nonproduction
DepreciationNonproduction
188000
CY2018Q3 us-gaap Depreciation Nonproduction
DepreciationNonproduction
67000
CY2017 us-gaap Derivative Average Remaining Maturity1
DerivativeAverageRemainingMaturity1
P2Y1M6D
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
23000
CY2017Q4 us-gaap Direct Financing Lease Deferred Selling Profit
DirectFinancingLeaseDeferredSellingProfit
830000
CY2018Q3 us-gaap Direct Financing Lease Deferred Selling Profit
DirectFinancingLeaseDeferredSellingProfit
687000
us-gaap Dividend Income Operating
DividendIncomeOperating
108000
CY2017Q3 us-gaap Dividend Income Operating
DividendIncomeOperating
45000
us-gaap Dividend Income Operating
DividendIncomeOperating
145000
CY2018Q3 us-gaap Dividend Income Operating
DividendIncomeOperating
50000
CY2017Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
187000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.34
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.69
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.67
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
CY2017Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.326
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.191
CY2018Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.184
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340
CY2017Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2018Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.004
CY2017Q3 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.003
us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.002
CY2018Q3 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.002
us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.000
CY2017Q3 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.000
us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.009
CY2018Q3 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.016
us-gaap Effective Income Tax Rate Reconciliation Tax Credits Other
EffectiveIncomeTaxRateReconciliationTaxCreditsOther
0.000
CY2017Q3 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Other
EffectiveIncomeTaxRateReconciliationTaxCreditsOther
0.000
us-gaap Effective Income Tax Rate Reconciliation Tax Credits Other
EffectiveIncomeTaxRateReconciliationTaxCreditsOther
0.006
CY2018Q3 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Other
EffectiveIncomeTaxRateReconciliationTaxCreditsOther
0.006
us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
-0.014
CY2017Q3 us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
-0.011
us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
-0.006
CY2018Q3 us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
-0.006
us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
4000
CY2017Q3 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
13000
us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
66000
CY2018Q3 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-208000
CY2017Q4 us-gaap Fair Value Option Loans Held As Assets Aggregate Difference
FairValueOptionLoansHeldAsAssetsAggregateDifference
4000
us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
221000
CY2017Q3 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
64000
us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
328000
CY2018Q3 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
141000
CY2017Q4 us-gaap Federal Home Loan Bank Advances Long Term
FederalHomeLoanBankAdvancesLongTerm
13500000
CY2018Q3 us-gaap Federal Home Loan Bank Advances Long Term
FederalHomeLoanBankAdvancesLongTerm
21500000
CY2017Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
3227000
CY2018Q3 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
3476000
CY2017Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
6944000
CY2018Q3 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
6981000
CY2017Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
26000
CY2018Q3 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
24000
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
0
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
0
CY2017Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
409800000
CY2018Q3 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
497183000
CY2017Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
3576000
CY2018Q3 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
3351000
us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
1
CY2017Q3 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
0
us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
0
CY2018Q3 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
0
us-gaap Financing Receivable Modifications Pre Modification Recorded Investment2
FinancingReceivableModificationsPreModificationRecordedInvestment2
841000
CY2017Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
3386000
CY2018Q3 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
3266000
us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
0
us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
0
CY2017Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
CY2018Q3 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
CY2017Q4 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
411509000
CY2018Q3 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
500402000
CY2017Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
470000
CY2018Q3 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
377000
CY2017Q4 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
1867000
CY2018Q3 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
132000
us-gaap Foreclosed Real Estate Expense
ForeclosedRealEstateExpense
18000
us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
59000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
70000
CY2017Q3 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
23000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
1268000
CY2018Q3 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
451000
us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
4742000
CY2017Q3 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
4590000
us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
3474000
us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
168000
CY2017Q3 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
58000
us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
155000
us-gaap Impaired Financing Receivable Interest Income Cash Basis Method
ImpairedFinancingReceivableInterestIncomeCashBasisMethod
164000
CY2017Q3 us-gaap Impaired Financing Receivable Interest Income Cash Basis Method
ImpairedFinancingReceivableInterestIncomeCashBasisMethod
52000
us-gaap Impaired Financing Receivable Interest Income Cash Basis Method
ImpairedFinancingReceivableInterestIncomeCashBasisMethod
151000
CY2018Q3 us-gaap Impaired Financing Receivable Interest Income Cash Basis Method
ImpairedFinancingReceivableInterestIncomeCashBasisMethod
52000
CY2017Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
3576000
CY2018Q3 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
3351000
CY2017Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
26000
CY2018Q3 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
24000
CY2017Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
3830000
CY2018Q3 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
3605000
us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
144000
CY2017Q3 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
140000
us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
132000
CY2018Q3 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
129000
us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
20000
CY2017Q3 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
6000
us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
16000
CY2018Q3 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
5000
CY2017Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
137000
CY2018Q3 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
128000
CY2017Q4 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
391000
CY2018Q3 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
382000
us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
4598000
CY2017Q3 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
4450000
us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
3342000
CY2018Q3 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
3296000
us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
148000
CY2017Q3 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
52000
us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
139000
CY2017Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
3439000
CY2018Q3 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
3223000
CY2017Q4 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
3439000
CY2018Q3 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
3223000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
33000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2455000
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1017000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3681000
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1294000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
605000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
660000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
810000
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
332000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
704000
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
239000
CY2017 us-gaap Income Tax Reconciliation Deductions Other
IncomeTaxReconciliationDeductionsOther
2250000
us-gaap Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance
IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance
-226000
us-gaap Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance
IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance
-40000
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
5589000
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
113034000
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
176000
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
634000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
785000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1173000
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
209477
CY2017Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
209477
CY2018Q3 us-gaap Interest Expense Subordinated Notes And Debentures
InterestExpenseSubordinatedNotesAndDebentures
68000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
9972000
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
51127
CY2018Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
65894
CY2017Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
1246753
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
36370
CY2017Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
41688
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
43344
CY2018Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
49508
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
775000
CY2017Q3 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
197000
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
733000
CY2018Q3 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
275000
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
12438000
CY2017Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
4397000
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
17592000
CY2018Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
6621000
us-gaap Interest And Dividend Income Securities Available For Sale
InterestAndDividendIncomeSecuritiesAvailableForSale
139000
CY2017Q3 us-gaap Interest And Dividend Income Securities Available For Sale
InterestAndDividendIncomeSecuritiesAvailableForSale
44000
us-gaap Interest And Dividend Income Securities Available For Sale
InterestAndDividendIncomeSecuritiesAvailableForSale
139000
CY2018Q3 us-gaap Interest And Dividend Income Securities Available For Sale
InterestAndDividendIncomeSecuritiesAvailableForSale
49000
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
11944000
CY2017Q3 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
4225000
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
16863000
CY2018Q3 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
6380000
us-gaap Interest And Fee Income Loans And Leases Held For Sale
InterestAndFeeIncomeLoansAndLeasesHeldForSale
39000
CY2017Q3 us-gaap Interest And Fee Income Loans And Leases Held For Sale
InterestAndFeeIncomeLoansAndLeasesHeldForSale
10000
us-gaap Interest And Fee Income Loans And Leases Held For Sale
InterestAndFeeIncomeLoansAndLeasesHeldForSale
451000
CY2017Q4 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
329440000
CY2018Q3 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
440979000
CY2017Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
100000
CY2018Q3 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
100000
us-gaap Interest Expense
InterestExpense
2466000
CY2017Q3 us-gaap Interest Expense
InterestExpense
893000
us-gaap Interest Expense
InterestExpense
4651000
CY2018Q3 us-gaap Interest Expense
InterestExpense
1938000
us-gaap Interest Expense Deposits
InterestExpenseDeposits
2115000
CY2017Q3 us-gaap Interest Expense Deposits
InterestExpenseDeposits
771000
us-gaap Interest Expense Deposits
InterestExpenseDeposits
4037000
CY2018Q3 us-gaap Interest Expense Deposits
InterestExpenseDeposits
1707000
us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm
195000
CY2017Q3 us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm
68000
us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm
420000
CY2018Q3 us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm
163000
us-gaap Interest Expense Subordinated Notes And Debentures
InterestExpenseSubordinatedNotesAndDebentures
156000
CY2017Q3 us-gaap Interest Expense Subordinated Notes And Debentures
InterestExpenseSubordinatedNotesAndDebentures
54000
us-gaap Interest Expense Subordinated Notes And Debentures
InterestExpenseSubordinatedNotesAndDebentures
194000
CY2017Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
3504000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
12941000
CY2018Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
4683000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
9972000
CY2017Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
3504000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
12941000
CY2018Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
4683000
us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
247000
CY2017Q3 us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
83000
us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
445000
CY2018Q3 us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
142000
CY2017Q4 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
1124000
CY2018Q3 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
24079000
us-gaap Interest Paid Net
InterestPaidNet
2479000
us-gaap Interest Paid Net
InterestPaidNet
4533000
CY2017Q4 us-gaap Interest Rate Derivatives At Fair Value Net
InterestRateDerivativesAtFairValueNet
-56000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
4450000
CY2017Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
1544000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
6026000
CY2018Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2116000
CY2017Q4 us-gaap Liabilities
Liabilities
441164000
CY2018Q3 us-gaap Liabilities
Liabilities
562792000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
481425000
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
606379000
us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
100000
us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
102000
CY2018Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
8000000
us-gaap Loan Portfolio Expense
LoanPortfolioExpense
124000
CY2017Q3 us-gaap Loan Portfolio Expense
LoanPortfolioExpense
45000
us-gaap Loan Portfolio Expense
LoanPortfolioExpense
72000
CY2018Q3 us-gaap Loan Portfolio Expense
LoanPortfolioExpense
29000
CY2016Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
6925000
CY2017Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
6958000
CY2017Q3 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
6964000
CY2017Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
6970000
CY2018Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
6981000
CY2018Q3 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
7005000
CY2017Q4 us-gaap Loans And Leases Receivable Impaired Commitment To Lend
LoansAndLeasesReceivableImpairedCommitmentToLend
0
CY2018Q3 us-gaap Loans And Leases Receivable Impaired Commitment To Lend
LoansAndLeasesReceivableImpairedCommitmentToLend
0
CY2017Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
413376000
CY2018Q3 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
500534000
CY2017Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
406406000
CY2018Q3 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
493529000
CY2017Q4 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
1124000
CY2018Q3 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
24079000
CY2017Q4 us-gaap Long Term Debt
LongTermDebt
13500000
CY2018Q3 us-gaap Long Term Debt
LongTermDebt
21500000
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
97000
CY2017Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
48000
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
1004000
CY2018Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
367000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10301000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
121138000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-40750000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-87151000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
464000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20117000
us-gaap Net Income Loss
NetIncomeLoss
1645000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
685000
us-gaap Net Income Loss
NetIncomeLoss
2977000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
1055000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1002000
CY2017Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
471000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2913000
CY2018Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1029000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1002000
CY2017Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
685000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
2913000
CY2018Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1029000
CY2017Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
89588000
CY2018Q3 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
91083000
us-gaap Noninterest Expense
NoninterestExpense
8055000
CY2017Q3 us-gaap Noninterest Expense
NoninterestExpense
2682000
us-gaap Noninterest Expense
NoninterestExpense
11116000
CY2018Q3 us-gaap Noninterest Expense
NoninterestExpense
4032000
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
218000
CY2017Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
76000
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
301000
CY2018Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
106000
us-gaap Noninterest Income
NoninterestIncome
538000
CY2017Q3 us-gaap Noninterest Income
NoninterestIncome
195000
us-gaap Noninterest Income
NoninterestIncome
1856000
CY2018Q3 us-gaap Noninterest Income
NoninterestIncome
643000
us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
78000
CY2017Q3 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
33000
us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
122000
CY2018Q3 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
30000
us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
70000
us-gaap Occupancy Net
OccupancyNet
503000
CY2017Q3 us-gaap Occupancy Net
OccupancyNet
170000
us-gaap Occupancy Net
OccupancyNet
573000
CY2018Q3 us-gaap Occupancy Net
OccupancyNet
224000
CY2017Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
23059000
CY2017Q4 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
6977000
CY2017Q4 us-gaap Other Assets
OtherAssets
4699000
CY2018Q3 us-gaap Other Assets
OtherAssets
5872000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-6000
CY2017Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-3000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-85000
CY2018Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-16000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Before Reclassification Adjustments Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax
-3000
CY2017Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Before Reclassification Adjustments Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax
-2000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Before Reclassification Adjustments Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax
-18000
CY2018Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Before Reclassification Adjustments Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax
-3000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-6000
CY2017Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-85000
CY2018Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-16000
us-gaap Other Noninterest Expense
OtherNoninterestExpense
149000
CY2017Q3 us-gaap Other Noninterest Expense
OtherNoninterestExpense
56000
us-gaap Other Noninterest Expense
OtherNoninterestExpense
297000
CY2018Q3 us-gaap Other Noninterest Expense
OtherNoninterestExpense
103000
us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
15318000
us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
158595000
us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
41517000
us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
61147000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
562000
us-gaap Payments To Acquire Available For Sale Securities Equity
PaymentsToAcquireAvailableForSaleSecuritiesEquity
1475000
us-gaap Payments To Acquire Federal Reserve Stock
PaymentsToAcquireFederalReserveStock
1285000
us-gaap Payments To Acquire Federal Reserve Stock
PaymentsToAcquireFederalReserveStock
249000
us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
25958000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
293000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
411000
CY2017Q4 us-gaap Pledged Assets Separately Reported Securities Pledged As Collateral At Fair Value
PledgedAssetsSeparatelyReportedSecuritiesPledgedAsCollateralAtFairValue
6804000
CY2018Q3 us-gaap Pledged Assets Separately Reported Securities Pledged As Collateral At Fair Value
PledgedAssetsSeparatelyReportedSecuritiesPledgedAsCollateralAtFairValue
6641000
CY2017Q4 us-gaap Pledged Assets Separately Reported Securities Pledged For Federal Home Loan Bank At Fair Value
PledgedAssetsSeparatelyReportedSecuritiesPledgedForFederalHomeLoanBankAtFairValue
4641000
CY2018Q3 us-gaap Pledged Assets Separately Reported Securities Pledged For Federal Home Loan Bank At Fair Value
PledgedAssetsSeparatelyReportedSecuritiesPledgedForFederalHomeLoanBankAtFairValue
4540000
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
643000
CY2017Q3 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
214000
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
64000
CY2018Q3 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
26000
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q3 us-gaap Preferred Stock Value
PreferredStockValue
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
364000
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
128000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt 0pt 8pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Reclassifications</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Reclassification of certain amounts in the 2017 consolidated financial statements have been made to conform to the 2018 presentation.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p><font size="1"> </font></p> </div> </div>
CY2012 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
22500000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
34200000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
74600000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
2148000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
2089000
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
0
CY2017Q3 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
0
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
0
CY2018Q3 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
0
us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
197000
us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
14691000
us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
136908000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
144000
us-gaap Professional Fees
ProfessionalFees
694000
CY2017Q3 us-gaap Professional Fees
ProfessionalFees
218000
us-gaap Professional Fees
ProfessionalFees
862000
CY2018Q3 us-gaap Professional Fees
ProfessionalFees
358000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3533000
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3723000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
CY2017Q3 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
CY2018Q3 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
0
CY2017Q3 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
0
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
0
CY2018Q3 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
0
us-gaap Repayments Of Debt
RepaymentsOfDebt
28700000
us-gaap Repayments Of Debt
RepaymentsOfDebt
66600000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17087000
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14174000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
290000
CY2017Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
106000
CY2018Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived
6244000
CY2018Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Five Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFiveYears
793000
CY2018Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Four Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears
793000
CY2018Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Remainder Of Fiscal Year
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear
198000
CY2018Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Thereafter
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThereafter
2874000
CY2018Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Three Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears
793000
CY2018Q3 us-gaap Tier One Leverage Capital Required To Be Well Capitalized
TierOneLeverageCapitalRequiredToBeWellCapitalized
28540000
CY2017Q4 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
0.0500
CY2018Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Two Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears
793000
us-gaap Supplies And Postage Expense
SuppliesAndPostageExpense
145000
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
39292000
CY2018Q3 us-gaap Supplies And Postage Expense
SuppliesAndPostageExpense
44000
us-gaap Taxes Other
TaxesOther
264000
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
40550000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
40261000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
43587000
CY2018Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
5.5
us-gaap Supplies And Postage Expense
SuppliesAndPostageExpense
138000
CY2017Q3 us-gaap Supplies And Postage Expense
SuppliesAndPostageExpense
46000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
119.35
CY2017Q3 us-gaap Taxes Other
TaxesOther
88000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
11.42
us-gaap Taxes Other
TaxesOther
308000
CY2018Q3 us-gaap Taxes Other
TaxesOther
103000
us-gaap Share Based Compensation
ShareBasedCompensation
181000
CY2017Q3 us-gaap Share Based Compensation
ShareBasedCompensation
59000
us-gaap Share Based Compensation
ShareBasedCompensation
290000
CY2018Q3 us-gaap Share Based Compensation
ShareBasedCompensation
99000
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
758466000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
96573
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
54
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
72
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
545
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1401
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
727
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
758466000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
98046
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
96573
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.78
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y8M12D
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
7.78
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P4Y8M12D
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
CY2017Q4 us-gaap Subordinated Debt
SubordinatedDebt
5155000
CY2018Q3 us-gaap Subordinated Debt
SubordinatedDebt
5155000
CY2017Q4 us-gaap Tier One Leverage Capital
TierOneLeverageCapital
43179000
CY2018Q3 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
0.0500
CY2017Q4 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
0.0937
CY2018Q3 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
0.0941
CY2018Q3 us-gaap Tier One Leverage Capital
TierOneLeverageCapital
53740000
CY2017Q4 us-gaap Tier One Leverage Capital Required To Be Well Capitalized
TierOneLeverageCapitalRequiredToBeWellCapitalized
23040000
CY2017Q4 us-gaap Tier One Risk Based Capital
TierOneRiskBasedCapital
43179000
CY2018Q3 us-gaap Tier One Risk Based Capital
TierOneRiskBasedCapital
53740000
CY2017Q4 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized
TierOneRiskBasedCapitalRequiredToBeWellCapitalized
32426000
CY2018Q3 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized
TierOneRiskBasedCapitalRequiredToBeWellCapitalized
39826000
CY2017Q4 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.0800
CY2018Q3 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.0800
CY2017Q4 us-gaap Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
0.1065
CY2018Q3 us-gaap Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
0.1080
CY2017Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
27701
CY2018Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
27701
CY2017Q4 us-gaap Treasury Stock Value
TreasuryStockValue
3324000
CY2018Q3 us-gaap Treasury Stock Value
TreasuryStockValue
3324000
CY2017Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
-214000
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2018Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3207223
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4367222
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
2961376
CY2017Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
2960378
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
4247800
CY2018Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
4251820
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2961376
CY2017Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2960378
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4247800
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4251820

Files In Submission

Name View Source Status
0001070680-18-000039-index-headers.html Edgar Link pending
0001070680-18-000039-index.html Edgar Link pending
0001070680-18-000039.txt Edgar Link pending
0001070680-18-000039-xbrl.zip Edgar Link pending
cfbk-20180930.xml Edgar Link completed
cfbk-20180930.xsd Edgar Link pending
cfbk-20180930x10q.htm Edgar Link pending
cfbk-20180930xex11_1.htm Edgar Link pending
cfbk-20180930xex31_1.htm Edgar Link pending
cfbk-20180930xex31_2.htm Edgar Link pending
cfbk-20180930xex32_1.htm Edgar Link pending
cfbk-20180930_cal.xml Edgar Link unprocessable
cfbk-20180930_def.xml Edgar Link unprocessable
cfbk-20180930_lab.xml Edgar Link unprocessable
cfbk-20180930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending